Analysis published 12 Oct 2026

AI-generated · cited to primary sources · not investment advice

Apollo Hospitals (508869) Feb 2026 Filing Analysis

01 · Management Credibility

Does management do what it says?

In progressNew Bed Maturity Timeline
60/100

Management reaffirmed the approximately ₹150 crore new-unit loss estimate for the coming fiscal year. Q3 reported numbers included approximately ₹15 crore of losses for Pune and Athena, with management noting this reflected three months of costs but only around one to 1.5 months of revenue. The 12-month individual-hospital breakeven objective was not updated. (5 in progress across 5 tracked commitments)

“In 2 years, we should be breakeven on 1,300 beds that we are talking about.”

Apollo Hospitals · Concall Transcript · Feb 2026 · p.17
In progressOccupancy Is Primary Margin Lever
60/100

Management reiterated at least 100 basis points of Healthcare Services margin improvement in FY27, specifying that this applies to established units. Established-hospital EBITDA margin was 25.5% in Q4 FY26, but the FY27 target is not yet due. (2 in progress across 2 tracked commitments)

“So as we look at our assets and occupancy and even in spite of bringing down the ALOS, we have a headroom for lifting volume and asset utilization by another 8%. We will focus on this as we go forward into the New Year. The second, of course, we have not done any significant cost cutting, which we hope will bring us another 80-100 basis points. With this, we hope to minimize the losses coming from new hospitals.”

Apollo Hospitals · Concall Transcript · Feb 2026 · p.14
Case Mix Determines ARPOB Trajectory

Management's growth mix aspiration for organic hospital growth is approximately half volume and half case mix and pricing. — target: For 12%–14% organic growth, approximately half from volume and half from case mix and pricing (+1 more commitment)

“So we would like to believe that when it is a 12%, 13% organic growth that we look at of 14%, we would like to be half on the volume and the balance half on combination of case mix and pricing.”

Apollo Hospitals · Concall Transcript · Feb 2026 · p.14

See the full cited Management analysis of Apollo Hospitals

Create free account →
02 · Business Model

How durable is the business?

Average Revenue Per Occupied Bed
80/100

Hospital revenue grew 14% year on year in Q3 FY26, from ₹27,850 million to ₹31,832 million. The segment remained a major contributor to Apollo’s business, though its share of consolidated revenue was about 49.1% in Q3 FY26, below the 50.6% reported for Q1 FY27 in the later baseline. (2 expanding)

“Revenue 31,832 27,850 14%; Healthcare Services Revenue grew by 14% in Q3FY26 (Inpatient Volume grew by 4%; Price of 3% and case mix of 7%).”

Apollo Hospitals · Investor PPT · Feb 2026 · p.15

See the full cited Business Model analysis of Apollo Hospitals

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.